Suppressive effects of 17β-estradiol on hepatic fibrosis in CCl4-induced rat model

Table 1 Change of liver enzymes and serum fibrosis indicators

		ALT (nkat/L)	AST (nkat/L)	HA (μg/L)	C IV (μg/L)
Control		275.50 ± 32.05	84.80 ± 11.83	155.50 ± 10.41	17.10 ± 1.77
CCl4	1	070.71 ± 82.95b	806.00 ± 82.43b	481.43 ± 24.68b	49.57 ± 2.47b
Ovx + CCl4	1	403.88 ± 120.30ab	1 102.88 ± 84.91bd	583.75 ± 37.50ab	61.00 ± 3.30ab
CCl4 + β-Est		789.40 ± 58.61ab	606.70 ± 45.68ab	389.30 ± 29.77ab	38.80 ± 2.59ab
Ovx + CCl4 + β-Est	1	008.44 ± 93.07b	794.89 ± 70.93b	474.56 ± 32.57b	46.22 ± 3.06b

^aP < 0.05 vs CCl₄ ,

^bP < 0.01 vs Control,

^dP < 0.01 vs CCl_4.